|
2.6 Digestion of Restriction Sites Close to the
End of Linear DNA
-
Multiple Digests
-
PCR Products
-
References
In order to recognize and cleave their recognition sequence, most restriction enzymes
need some flanking DNA. Because of this it can be difficult to achieve complete digestion
of PCR(a) products that have restriction sites engineered
near the end of a primer or to perform double digests using two enzymes that cut at sites
close to each other in a polylinker region. Such digestions may be improved by using long
(16-hour) incubation times.
A. Multiple Digests
When performing multiple digests within a polylinker region, it is important to
determine if the sites overlap such that cleavage at one site will destroy another. For
example, the sequence below contains both a Kpn I (GGTAC/C) and a Sma I
(CCC/GGG) site.
...NNNNNGGTACCCGGGNNNNN...
...NNNNNCCATGGGCCCNNNNN...
If this DNA is first digested with Kpn I, it will leave the following sequence,
which cannot be digested with Sma I.
...NNNNNGGTAC CCGGGNNNNN...
...NNNNNC CATGGGCCCNNNNN...
Alternatively, if the DNA is first digested with Sma I, it will leave the
sequence shown below, which can be digested with Kpn I, although there may be
problems due to a lack of flanking bases.
...NNNNNGGTACCC GGGNNNNN...
...NNNNNCCATGGG CCCNNNNN...
Studies by Kaufman and Evans (1), and Moreira and Noren (2) show the efficiency of
digestion of polylinker regions with a variety of enzymes. This data can be used to help
determine the order in which two enzymes should be used for the most efficient multiple
digests, or to predict whether enzymes will work effectively in a double-digest. Care must
be taken when applying the conclusions from these publications to the digestion of PCR
products because the majority of the ends left by restriction enzymes have 2-4 base 3´ or
5´ overhangs. Generally, PCR products are either blunt ended (if a proofreading
thermostable polymerase is used) or contain a single 3´ overhanging base (if a
non-proofreading enzyme is used).
B. PCR Products
In general, the addition of 2-6 extra bases upstream of an engineered restriction site
in a PCR primer will greatly increase the efficiency of digestion of the amplification
product, but this is dependent on the enzyme used. Table 2.6 shows the results of a study
where the ability of restriction enzymes to digest various PCR products was tested (3).
PCR products in which the first base pair of the restriction site was flush with (0), or
1, 2, or 3 base pairs away from the end of the fragment were tested with a variety of
enzymes.
Table 2.6. Ability of Restriction Enzymes to Cut PCR Products that have
Engineered Restriction Sites Near the End of the Fragment.
|
Enzyme |
Distance (in bp)
from the
End of the PCR Fragment |
0 |
1 |
2 |
3 |
| Apa I |
– |
– |
± |
+ |
| BamH I |
– |
± |
+ |
+ |
| BstX I |
– |
± |
+ |
+ |
| Cla I |
– |
± |
+ |
+ |
| EcoR I |
– |
± |
+ |
+ |
| EcoR V |
– |
+ |
+ |
+ |
| Hind III |
– |
– |
+ |
+ |
| Not I |
– |
– |
+ |
+ |
| Pst I |
– |
– |
± |
+ |
| Sac I |
– |
± |
+ |
+ |
| Sal I |
+ |
+ |
+ |
+ |
| Sma I |
– |
± |
+ |
+ |
| Spe I |
+ |
+ |
+ |
+ |
| Xba I |
– |
± |
+ |
+ |
| Xho I |
– |
– |
± |
+ |
The addition of upstream bases to PCR primers is not the only method used to improve
digestion efficiency. A number of protocols have been proposed to improve digestion
including proteinase K treatment to remove any thermostable polymerase that may be
blocking the DNA, end-polishing with Klenow or T4 DNA Polymerase and the addition of
spermidine. However, none of these methods have been shown to improve cloning efficiency
significantly (4,5).
An additional drawback to the incorporation of restriction enzyme sites in PCR primers
is that it can be quite difficult to resolve digested PCR products from those that remain
uncut. This can be overcome by the addition of fluorescent tags at the 5´ ends of the
primers prior to PCR. This allows identification of products that have been cut
successfully because the label is lost upon digestion (6).
An alternative method that has been used successfully to improve digestion of PCR
products is to concatamerize the fragments after amplification (1,5). This is achieved by
first treating the cleaned up PCR products with T4 Polynucleotide Kinase (if the primers
have not already been phosphorylated). The ends will already be blunt if a proofreading
thermostable polymerase such as Pfu(b) was used or may be treated with
T4 DNA Polymerase to polish the ends if a non-proofreading polymerase such as Taq(b)
was used (5). PCR products are then ligated with T4 DNA ligase. This effectively moves the
restriction enzyme sites away from the ends of the fragments and allows efficient
digestion.
C. References
- Kaufman, D.L., and Evans, G.A. (1990) Restriction endonuclease cleavage at the termini
of PCR products. BioTechniques 9, 304.
- Moreira, R.F., and Noren, C.J. (1995) Minimum duplex requirements for restriction enzyme
cleavage near the termini of linear DNA fragments. BioTechniques 19, 56.
- Zimmermann, K. et al. (1998) Digestion of terminal restriction endonuclease
recognition sites on PCR products. BioTechniques 24, 582.
- Jung, V. et al. (1990) Efficient cloning of PCR generated DNA containing terminal
restriction endonuclease recognition sites. Nucl. Acids Res. 18, 6156.
- Jung, V. et al. (1993) Cloning of polymerase chain reaction-generated DNA
containing terminal restriction endonuclease recognition sites. Meth. Enzymol. 218,
357.
- Yamaguchi, K. et al. (1994) Fluorescent primers allow direct confirmation of
restriction enzyme cleavage of PCR products. BioTechniques 17, 649.
(a)The PCR process is covered by
patents issued and applicable in certain countries. Promega does not encourage or support
the unauthorized or unlicensed use of the PCR process.
(b)Some applications in which this product may be used are covered by patents
issued and applicable in certain countries. Because purchase of this product does not
include a license to perform any patented application, users of this product may be
required to obtain a patent license depending upon the particular application and country
in which the product is used. For more specific information, please contact Promega.
-top of page-
Table of Contents
|